Chemotherapy Poised to Deliver a Double Punch
Chemotherapy Poised to Deliver a Double Punch Source: Rita Serda and NIH December 9, 2020 Share A new study provides an explanation as to why cancer immunotherapy currently fails in many patients and offers a potential solution that could increase the efficacy of anticancer drugs. Currently, 70 to 85% of patients taking immunotherapy drugs fail to respond to them. Kazukuni Hayashi, PhD In the study conducted on laboratory mice, Kazukani Hayashi, PhD, and a team of cancer researchers at Cedars-Sinai, showed that combining the chemotherapy drug, Gemcitabine, with the anti-inflammatory drug, Ce...
Source: genengnews.com